Indian Generics Manufacturer Fails to Meet Standards, UK Inspectors Say

Drug GMP Report
A A
UK regulators moved to block imports to the European Union from a generic drug manufacturer in India after reporting deficiencies in quality control, processing, laboratory testing and safeguards against contamination.

To View This Article:

Login

Subscribe To Drug GMP Report